# Thrombolysis in Ischemic Spinal Cord Stroke

> **NCT02242084** · PHASE2 · TERMINATED · sponsor: **Rabin Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Motor Weakness in Two or Four Limbs
- Damage in the Anterior Spinal Artery (ASA)
- Temperature and Superficial Sensation
- Urinary Retention or Bowel Disorder

## Interventions

- **DRUG:** Intravenuse Alteplase

## Key facts

- **NCT ID:** NCT02242084
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04
- **Primary completion:** 2019-03-26
- **Final completion:** 2019-03-26
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02242084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02242084, "Thrombolysis in Ischemic Spinal Cord Stroke". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02242084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*